These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28645757)

  • 41. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs.
    Feng Q; Lu C; Wang L; Song L; Li C; Uppada RC
    BMC Cardiovasc Disord; 2017 Feb; 17(1):65. PubMed ID: 28212603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
    Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
    Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study.
    Bosselmann H; Tonder N; Sölétormos G; Rossing K; Iversen K; Goetze JP; Gustafsson F; Schou M
    Int J Cardiol; 2014 Dec; 177(3):942-8. PubMed ID: 25449505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension.
    Damascelli B; Patelli G; Tichá V; Della Rocca F; Lattuada S; Sala C; Albertoni A; D'Alessio A; Funaro A; Scotti L
    J Vasc Interv Radiol; 2013 May; 24(5):632-9. PubMed ID: 23622036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction.
    Schirmer SH; Sayed MM; Reil JC; Ukena C; Linz D; Kindermann M; Laufs U; Mahfoud F; Böhm M
    J Am Coll Cardiol; 2014 May; 63(18):1916-23. PubMed ID: 24315919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study.
    Gaggin HK; Mohammed AA; Bhardwaj A; Rehman SU; Gregory SA; Weiner RB; Baggish AL; Moore SA; Semigran MJ; Januzzi JL
    J Card Fail; 2012 Aug; 18(8):626-34. PubMed ID: 22858078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH; Sayed MM; Reil JC; Lavall D; Ukena C; Linz D; Mahfoud F; Böhm M
    JACC Cardiovasc Interv; 2015 Jun; 8(7):972-80. PubMed ID: 26003031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal sympathetic denervation suppresses ventricular substrate remodelling in a canine high-rate pacing model.
    Dai Z; Yu S; Zhao Q; Meng Y; He H; Tang Y; Wang X; Xiao J; Wang X; Huang C
    EuroIntervention; 2014 Jul; 10(3):392-9. PubMed ID: 25042267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
    Weiner RB; Baggish AL; Chen-Tournoux A; Marshall JE; Gaggin HK; Bhardwaj A; Mohammed AA; Rehman SU; Barajas L; Barajas J; Gregory SA; Moore SA; Semigran MJ; Januzzi JL
    Eur J Heart Fail; 2013 Mar; 15(3):342-51. PubMed ID: 23132825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence.
    Nammas W; Koistinen J; Paana T; Karjalainen PP
    Ann Med; 2017 Aug; 49(5):384-395. PubMed ID: 28276870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure.
    Böhm M; Ewen S; Linz D; Reil JC; Schirmer SH; Ukena C; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R122-6. PubMed ID: 23732144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal Denervation Improves Exaggerated Sympathoexcitation in Rats With Heart Failure: A Role for Neuronal Nitric Oxide Synthase in the Paraventricular Nucleus.
    Patel KP; Xu B; Liu X; Sharma NM; Zheng H
    Hypertension; 2016 Jul; 68(1):175-84. PubMed ID: 27185748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
    Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.